Skip to content
Methodology
All entries for: ImCheck Therapeutics SA
July 11, 2025
ImCheck Therapeutics SA
Orphan Drug Designation
FDA orphan drug designation: treatment of acute myeloid leukemia
Disease Area:
Rare Diseases
Source
Scroll to Top